Clinical Trial Update: Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice

View source ↗

Summary

An update on the treatment of relapsed/refractory multiple myeloma with pomalidomide in clinical practice following completion of the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pomalyst (pomalidomide)

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Status: COMPLETED